Tag: biotechnology
-
Engineered Probiotic Maker Gains $2.3M Seed Funding
A developer of genetically-modified bacteria designed to work in the gut is raising $2.3 million more in seed funds to expand its product line.
-
Gates Funding Covid-19 Vaccine Delivery Device
A biotechnology company developing a vaccine for the Covid-19 virus received funding to scale up a delivery device for the vaccine when it’s available.
-
Engineered Viruses Deployed to Treat Gut Infections
Academic and industry researchers created gene-editing viruses that in lab cultures and mice killed bacteria causing often deadly intestinal infections.
-
Biotech Partners for A.I. Drug Discovery in $1B Deal
Two companies are collaborating on the use of artificial intelligence to find new drugs addressing a set of proteins that regulate immune-related functions, including inflammation.
-
Business-Foundation Alliance Funds Covid-19 Treatments
Two foundations and a credit card company are providing seed money for development and manufacture of treatments for the novel coronavirus or Covid-19 pandemic.
-
Coffee, Hemp Cells Set for Space Station Study
A company is sending cell cultures from hemp and coffee plants to the International Space Station to test effects of weightlessness on the plants’ gene expression.
-
Venom-Aided Immunotherapy Designed for Brain Tumors
Cancer researchers developed engineered immune-system cells, helped by peptides from scorpion venom, that in lab mice bind more reliably to brain tumor cells.
-
Patient Receives First Crispr Genetic Eye Treatment
An individual with a rare genetic eye disease received the first dose of an edited gene in a clinical trial of an experimental treatment for the disorder.
-
Proteins from Bacteria Generate Power for Wearables
A collaboration of engineers and biologists created a way of producing electric power from humidity in the air with fine wires made of proteins from bacteria.
-
Foundation Supports ALS Inflammation Treatments
A foundation is funding a biotechnology company’s research on therapies to block proteins encouraging neuron inflammation in people with amyotrophic lateral sclerosis, or ALS.